peptide version of tirzepatide GLP-2 (40mg vials) Compounded Tirzepatide: A Dual-Action Peptide

Share your interest in GLP-1 medications and discuss how the combination will be managed

Because the skin is thin, underlying blood vessels can show through more easily, especially when circulation slows or sleep is limited

It is important to note that its conditions of use is marketed and sold for research purposes only and not for human consumption

The effect of tirzepatide on 24-hour mean systolic BP, diastolic BP, and heart rate (HR) measured during 24-hour ambulatory BP monitoring (ABPM) in individuals living with obesity without T2DM, has been evaluated in the SURMOUNT-1 ABPM sub-study.34 After 36 weeks of treatment, tirzepatide was associated with statistically significant and clinically meaningful reductions in the mean 24-hour systolic BP at all doses and reduced diastolic BP at the 2 lower doses.34 Simultaneously, tirzepatide treatment was associated with a dose-dependent increase in the mean 24-hour HR.34 Fortunately, there is no clear evidence that tirzepatide increases the risk of atrial fibrillation.35 5

esculentum (Yamaguchi et al., 1995

In these settings, GLP-1 therapies are often positioned as part of a broader service package that includes coaching, lifestyle guidance, and ongoing support